Universal Detection Signs Exclusive Distribution Agreement with SSI to Market Anthrax Detector in Central and South America(LOS ANGELES, Oct. 24, 2005) -- Universal Detection Technology (OTCBB:UDTT) (FWB:PO8), a developer of early-warning monitoring technologies to protect people from bioterrorism and other infectious health threats, has signed an exclusive distribution agreement with Security Solutions International (SSI), a security services company, to distribute UDTT's anthrax and other bacterial spore monitoring system, BSM-2000, in Central and South America.
Under the agreement, SSI, a Miami-based counterterrorism training firm specializing in providing critical emergency preparedness support, will use its efforts to promote the marketing and distribution of the BSM-2000 in the Brazil, Venezuela and the Dominican Republic.
Military Global Navigation Satellite Systems (GNSS) Market Assessment
The agreement is designed to increase UDTT's marketing reach and product sales potential in international markets.
"We hope that BSM-2000 will attract great interest as a welcome security solution for public safety preparedness against increasing bioterrorism threats," said Jacques Tizabi, CEO of Los Angeles-based Universal Detection Technology. "Our goal is to generate new distribution channels domestically and internationally for BSM-2000 through the expansion of marketing and support networks. Our partnership with SSI is a clear step in that direction, which we expect will help foster our Company exposure and visibility in Latin America. While Latin American distribution is not within SSI's core business focus, we hope that its expertise in counter-terrorism and security training, and its existing relationships in Latin America will offer opportunities to extend our visibility to a number of neighbors to our South," he said.
Henry Morgenstern, SSI's president, said: "We believe that our relationships in Central and South America will provide us the opportunity to introduce UDT's BSM-2000 anthrax detector to a market outside the USA. The war on terror is a global problem and all countries realize that they are potential targets. We believe that the UDT technology will provide countries with safety in the face of this threat."
UDTT is focused on developing, distributing and deploying advanced early-warning monitoring and detection systems with cost and functional advantages over competing technologies available. The Company's product, the BSM-2000, is based on a spore detection technology developed by NASA and licensed exclusively by UDTT.
About Security Solutions International (SSI)
SSI is committed to bringing its expertise in global counterterrorism and security matters to practical application in a variety of customized training seminars and courses. These training services are designed provide the highest degree of emergency preparedness for ground, air and sea and catered to the needs of particular client organizations and agencies. For more information, please visit: www.securitysolutionsint.com.
About Universal Detection Technology
Universal Detection Technology (UDTT), founded in 1973, is a developer of advanced monitoring and early-warning technologies whose mission is to help meet today's heightened security and defense requirements in the global war on terror. The Company's intellectual property portfolio includes exclusive worldwide commercial licensing of technology developed by NASA's Jet Propulsion Laboratory (JPL) and its own proprietary aerosol capture technology, which are combined in the Company's initial monitoring device, the BSM-2000. Management believes that the Company's technology, together with third-party technologies and devices, has positioned it to capitalize on growth and value opportunities related to Homeland Security. For more information, please visit http://udtt.invrel.net or http://www.udetection.com. To view investor-specific information about the Company, including recent news and other data, please visit http://www.trilogy-capital.com/tcp/udt. To read or download an Investor Fact Sheet about the Company, please visit http://www.trilogy-capital.com/tcp/udt/factsheet.html. Universal Detection Technologies is also listed on the Frankfurt Stock Exchange under the ticker symbol PO8.
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results may vary substantially as a result of a variety of factors. Among the important factors that could cause actual results to differ are, the funding of amounts of capital adequate to provide for our working capital needs and our timely repayment of debt, results of the validation testing of the BSM-2000 undertaken by an independent third party, our ability to timely and cost effectively complete the development and testing of our products targeted to the bio-chemical market, our ability to commercially produce our products and do so on a profitable basis, commercial acceptance of our products, product price volatility, product demand, market competition and general economic conditions. These and other risk factors are discussed in our periodic reports filed with the SEC, including our Report on Form 10-K for the year ended December 31, 2004 and our periodic Reports on Form 10-Q for the quarters ended March 31, 2005, and June 30, 2005 and the reader is directed to these statements for a further discussion of important factors that could cause actual results to differ materially from those in the forward-looking statements.
Universal Detection Technology
Jacques Tizabi, 310-248-3655
Trilogy Capital Partners
Paul Karon, 800-592-6067
Source : Universal Detection Technology